1. Home
  2. CISO vs IGC Comparison

CISO vs IGC Comparison

Compare CISO & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • IGC
  • Stock Information
  • Founded
  • CISO 2015
  • IGC 2005
  • Country
  • CISO United States
  • IGC United States
  • Employees
  • CISO N/A
  • IGC N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • IGC Health Care
  • Exchange
  • CISO Nasdaq
  • IGC Nasdaq
  • Market Cap
  • CISO 32.7M
  • IGC 29.4M
  • IPO Year
  • CISO N/A
  • IGC N/A
  • Fundamental
  • Price
  • CISO $1.01
  • IGC $0.31
  • Analyst Decision
  • CISO
  • IGC Strong Buy
  • Analyst Count
  • CISO 0
  • IGC 2
  • Target Price
  • CISO N/A
  • IGC $3.75
  • AVG Volume (30 Days)
  • CISO 172.5K
  • IGC 367.3K
  • Earning Date
  • CISO 11-18-2024
  • IGC 02-18-2025
  • Dividend Yield
  • CISO N/A
  • IGC N/A
  • EPS Growth
  • CISO N/A
  • IGC N/A
  • EPS
  • CISO N/A
  • IGC N/A
  • Revenue
  • CISO $54,633,909.00
  • IGC $1,183,000.00
  • Revenue This Year
  • CISO $78.76
  • IGC N/A
  • Revenue Next Year
  • CISO N/A
  • IGC $13.38
  • P/E Ratio
  • CISO N/A
  • IGC N/A
  • Revenue Growth
  • CISO 34.87
  • IGC N/A
  • 52 Week Low
  • CISO $0.26
  • IGC $0.27
  • 52 Week High
  • CISO $3.84
  • IGC $0.91
  • Technical
  • Relative Strength Index (RSI)
  • CISO 38.46
  • IGC 35.18
  • Support Level
  • CISO $0.93
  • IGC $0.31
  • Resistance Level
  • CISO $1.10
  • IGC $0.33
  • Average True Range (ATR)
  • CISO 0.09
  • IGC 0.02
  • MACD
  • CISO 0.00
  • IGC -0.00
  • Stochastic Oscillator
  • CISO 41.51
  • IGC 3.89

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: